PMDA posts MHLW notice directing revision of precautions for drugs (dated 29 Sep 2026)
使用上の注意の改訂指示通知（医薬品）2026年9月29日付（厚生労働省より発出）を掲載しました
Published: 2026-09-29 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · First detected by this dashboard: 2026-09-30
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
PMDA's safety updates page lists a post stating that a notice instructing revisions to the 'Precautions' (package-insert cautionary information) for pharmaceuticals, issued by the Ministry of Health, Labour and Welfare and dated 29 September 2026, has been published. The available metadata does not identify which drugs or which precautions are affected. This is a government safety announcement; the specific content is not described in the provided information.
Business Impact
Marketing authorization holders and healthcare providers handling the affected drugs may need to update package inserts or related safety information, depending on the notice's content. The scope and impact cannot be determined from the metadata provided.
Recommended Action
Review the linked official PMDA/MHLW Japanese source to identify the specific drugs and revisions involved and to verify this unofficial summary.